You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 214 No. 5, November 2, 1970 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Control of Arteriovenous Shunt Flow

Allen C. Alfrey, MD; Richard Lueker, MD; Jerry E. Goss, MD; John H. K. Vogel, MD; Tanous D. Faris, MD; Joseph H. Holmes, MD

JAMA. 1970;214(5):884-888.


Abstract

The conditions of 25 patients with external arteriovenous shunts were studied to determine the factors important in control of shunt flow. Shunt flow varied between 1.9% and 9.8% of the cardiac output in seven studies performed in five patients. Change in posture, exercise, and dialysis had no consistent effect on shunt flow. Flow was primarily determined by systemic pressure, vascular reactivity, and the state of the cannulated vessels. Cold pressor test and angiotensin amide consistently increased flow in contrast to the fall in flow and increased shunt pressure induced with sympathomimetic agents. Studies in dogs demonstrated that the changes induced with the sympathomimetic agents were a consequence of arterial and venous constriction mediated through alpha-adrenergic receptors. Shunt flow and pressure measurements appeared to be useful in predicting shunt survival and determining the involved side of a malfunctioning shunt.



Author Affiliations

From the departments of medicine (Drs. Alfrey, Lueker, Goss, Vogel, and Holmes) and surgery (Dr. Faris), University of Colorado School of Medicine, Denver. Dr. Alfrey is now at the University of Texas (Southwestern) Medical School, Dallas. Drs. Lueker and Goss are now with the; University of New Mexico School of Medicine, Albuquerque. Dr. Vogel is now with the Santa Barbara (Calif) Heart and Lung Institute.


Footnotes

Reprint requests to 5323 Harry Hines Blvd, Dallas 75235 (Dr. Alfrey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevention of Arteriovenous Shunt Clotting
Modai et al.
JAMA 1974;230:427-430.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.